GB201305175D0 - Formulations of generic drugs against cancer and infectious diseases - Google Patents

Formulations of generic drugs against cancer and infectious diseases

Info

Publication number
GB201305175D0
GB201305175D0 GB201305175A GB201305175A GB201305175D0 GB 201305175 D0 GB201305175 D0 GB 201305175D0 GB 201305175 A GB201305175 A GB 201305175A GB 201305175 A GB201305175 A GB 201305175A GB 201305175 D0 GB201305175 D0 GB 201305175D0
Authority
GB
United Kingdom
Prior art keywords
formulations
infectious diseases
against cancer
drugs against
generic drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201305175A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB201305175A priority Critical patent/GB201305175D0/en
Publication of GB201305175D0 publication Critical patent/GB201305175D0/en
Ceased legal-status Critical Current

Links

GB201305175A 2013-03-21 2013-03-21 Formulations of generic drugs against cancer and infectious diseases Ceased GB201305175D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB201305175A GB201305175D0 (en) 2013-03-21 2013-03-21 Formulations of generic drugs against cancer and infectious diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201305175A GB201305175D0 (en) 2013-03-21 2013-03-21 Formulations of generic drugs against cancer and infectious diseases

Publications (1)

Publication Number Publication Date
GB201305175D0 true GB201305175D0 (en) 2013-05-01

Family

ID=48226791

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201305175A Ceased GB201305175D0 (en) 2013-03-21 2013-03-21 Formulations of generic drugs against cancer and infectious diseases

Country Status (1)

Country Link
GB (1) GB201305175D0 (en)

Similar Documents

Publication Publication Date Title
HK1255336A1 (en) Pharmaceutical formulations and processes of preparation thereof
ZA201505735B (en) Cancer drug and uses
HK1216991A1 (en) Cancer vaccines and methods of treatment using the same
HK1207636A1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
EP2981611A4 (en) Antibiotic protocells and related pharmaceutical formulations and methods of treatment
IL236221A (en) Thienopyridone derivatives and pharmaceutical compositions comprising them for the treatment of diseases
HK1210463A1 (en) Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
HK1221416A1 (en) Formulations of oxabicycloheptanes and oxabicycloheptenes
EP3010507A4 (en) Compositions and methods for potentiating immune response for the treatment of infectious diseases and cancer
WO2014127378A8 (en) Design of short oligonucleotides as vaccine adjuvants and therapeutic agents
PL3064491T3 (en) Sulfonamide derivative and medicinal use thereof
HK1218079A1 (en) Pharmaceutical formulations of nitrite and uses thereof
EP3068416A4 (en) Kava derived therapeutic compounds and methods of use thereof
IL244354A0 (en) Influenza vaccine and therapy
EP2974730A4 (en) Drug for respiratory diseases
SG11201509194SA (en) Radiomitigating pharmaceutical formulations
PT3228313T (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
GB201318686D0 (en) Pharmaceutical preparations
GB201301721D0 (en) Pharmaceutical Preparations
EP2941437A4 (en) Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
EP2984170A4 (en) Use of antibody-urease conjugates for diagnostic and therapeutic purposes
HK1217670A1 (en) Formulations of albu-bche, preparation and uses thereof albu-bche
GB201305175D0 (en) Formulations of generic drugs against cancer and infectious diseases
GB201509797D0 (en) Formulations of generic drugs against cancer and infectious diseases
GB201208492D0 (en) Formulations of generic drugs against cancer and infectious diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)